Hong, S., Yu, C., Wang, P., Shi, Y., Cao, W., Cheng, B., . . . Wu, P. (2020). Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy. Angew Chem Int Ed Engl.
Styl cytowania ChicagoHong, Senlian, et al. "Glycoengineering of NK Cells With Glycan Ligands of CD22 and Selectins for B-cell Lymphoma Therapy." Angew Chem Int Ed Engl 2020.
Styl cytowania MLAHong, Senlian, et al. "Glycoengineering of NK Cells With Glycan Ligands of CD22 and Selectins for B-cell Lymphoma Therapy." Angew Chem Int Ed Engl 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..